Borr Drilling Ltd Chief Executive Officer Bruno Morand De Oliveira filed a Form 4 on September 21, 2026, disclosing a purchase of 45,500 common shares on September 18, 2026.
David R. Price, CEO and Director of PriceSmart Inc., filed a Form 4 on September 18, 2026, disclosing the acquisition of 8,499 shares of restricted common stock on September 17, 2026, at no cost.
A Form 4 filed on September 21, 2026 reports that HUANG Duoduo (Howard), Chief Supply Chain Officer of Yum China Holdings, Inc. (NYSE:YUMC), acquired three tranches of Restricted Stock Units on September 17, 2026 as dividend equivalency payments on previously issued RSUs.
Joey Wat, Chief Executive Officer and Director of Yum China Holdings, Inc., filed a Form 4 on September 21, 2026, disclosing three acquisitions of Restricted Stock Units on September 17, 2026, representing dividend equivalency payments on previously granted RSUs.
Wang Warton, General Manager of KFC at Yum China Holdings, Inc., filed a Form 4 on September 21, 2026, reporting the acquisition of Restricted Stock Units as dividend equivalency payments on September 17, 2026.
Robert George Culp IV, President and CEO of Culp Inc, filed a Form 4 on September 21, 2026, disclosing a purchase of common stock on September 18, 2026, through the company's 401(k) plan.
Advasa Holdings (NASDAQ:ADBT) connects investors to a shift in the mechanics of pay: the idea that workers should be able to access the wages they've already earned before the traditional payday. Advasa, a Japan-based financial-technology company, provides earned-wage-access infrastructure, technology that lets employees draw …
Retail tenant quality shapes Agree Realty (NYSE:ADC) because the company's income comes from rent paid by retailers, and the reliability of that rent depends on how strong those retailers are. Agree Realty is a net-lease real estateInvestmenttrust: it owns freestanding retail properties and leases …
Targeted cancer treatments matter for ADC Therapeutics (NYSE:ADCT) because that's what the company makes: antibody-drug conjugates, or ADCs, a class of therapy designed to attack cancer more precisely than traditional chemotherapy. An ADC links an antibody, which seeks out a specific marker on cancer …
Trent N. Smith, Chief Financial Officer of Autonomix Medical, Inc. (NASDAQ:AMIX), filed a Form 4 on September 21, 2026, disclosing the acquisition of 15,000 shares of common stock on September 3, 2026, via a restricted stock award.